In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Me (ME), the company that popularized at-home DNA tests, announced on Tuesday that its sales took a hit during its most ...

The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.

This decision, described by CEO Anne Wojcicki as “difficult but necessary,” comes as the genetic testing company undergoes a ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...